Jefferies Raises Geberit Target to 712 CHF Amid Market Optimism

Geberit’s shares traded slightly higher at 564.40 CHF on Tuesday amid a broader market downturn, including a 1.4 percent drop in the Swiss Market Index (SMI) following a slide in Novartis shares. The Swiss-based company’s stock reflects renewed investor confidence, buoyed by a US analyst’s upward revision of its price target to 712 CHF, the highest among market participants and a signal of optimism for the sector’s recovery. Jefferies confirmed its buy recommendation, citing strong organic growth in Q2 and better-than-expected guidance on revenues and margins. Analyst Priyal Woolf noted that while Geberit’s current valuation—with a trailing P/E ratio of 28x—remains elevated compared to its 20-year average of 23.2x—it is not unprecedented, having peaked at similar levels in 2020–2022 or briefly in 2026—she sees significant upside potential from a projected European construction sector rebound. The market consensus, however, remains cautious. While five analysts still recommend buying, ten advise holding and seven urge selling, with the average target set at 578 CHF—a level that implies a modest 2 percent upside from the current price. The most optimistic rival, Oddo BHF, has set a target of 660 CHF, while Goldman Sachs follows closely at 652 CHF. On the other end of the spectrum, institutions like BNP Paribas, Bernstein, and Rothschild remain skeptical, projecting prices below 500 CHF over the next year. Their concerns center on Geberit’s valuation and the pace of a potential construction-sector recovery, which they argue may be slower than anticipated due to rising raw-material and energy costs.